Grateful to BBC News for spotlighting our work on progesterone-Callavid®, our novel drug delivery technology aimed at helping treat threatened miscarriage.

“The current delivery method can leak and cost the [British economy and] NHS up to £236m per year, health economists say. University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is leading the trial and said more than 150,000 women in the UK could be eligible for prescriptions of progesterone.”

We’re proud to be working on a solution with the potential for meaningful impact in women’s health

Article here: https://www.bbc.co.uk/news/articles/cd9l09zeqngo